Study: NCT00307034

Adverse event: Febrile convulsion (Booster phase)
Serious: yes
Organ System: Nervous system disorders
Frequency: 1 affected / 174 at risk

Adverse event: Dermatitis allergic (Primary phase)
Serious: yes
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 175 at risk

Adverse event: Respiratory syncytial virus infection (Primary phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 175 at risk

Adverse event: Gastroenteritis viral (Primary phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 175 at risk

Adverse event: Salmonellosis (Primary phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 175 at risk

Adverse event: Viral infection (Primary phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 175 at risk

Adverse event: Pneumonia (Booster phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 174 at risk

Adverse event: Urinary tract infection (Booster phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 174 at risk

Adverse event: Cough (Primary phase)
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 9 affected / 175 at risk

Adverse event: Cough (Booster phase)
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 6 affected / 174 at risk

Adverse event: Pain (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 92 affected / 175 at risk

Adverse event: Redness (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 137 affected / 175 at risk

Adverse event: Swelling (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 111 affected / 175 at risk

Adverse event: Pain (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 103 affected / 174 at risk

Adverse event: Redness (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 118 affected / 174 at risk

Adverse event: Swelling (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 97 affected / 174 at risk

Adverse event: Drowsiness (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 130 affected / 175 at risk

Adverse event: Fever- rectal (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 108 affected / 175 at risk

Adverse event: Irritability (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 149 affected / 175 at risk

Adverse event: Loss of appetite (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 81 affected / 175 at risk

Adverse event: Drowsiness (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 97 affected / 174 at risk

Adverse event: Fever- rectal (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 96 affected / 174 at risk

Adverse event: Irritability (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 113 affected / 174 at risk

Adverse event: Loss of appetite (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 61 affected / 174 at risk

Adverse event: Pyrexia (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 12 affected / 175 at risk

Adverse event: Pyrexia (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 8 affected / 174 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 11 affected / 175 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 4 affected / 175 at risk

Adverse event: Nasopharyngitis (Primary phase)
Serious: no
Organ System: Infections and infestations
Frequency: 26 affected / 175 at risk

Adverse event: Nasopharyngitis (Booster phase)
Serious: no
Organ System: Infections and infestations
Frequency: 16 affected / 174 at risk

Adverse event: Otitis media (Booster phase)
Serious: no
Organ System: Infections and infestations
Frequency: 9 affected / 174 at risk

Adverse event: Asthma (Primary phase)
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 176 at risk

Adverse event: Dyspepsia (Primary phase)
Serious: yes
Organ System: Gastrointestinal disorders
Frequency: 1 affected / 176 at risk

Adverse event: Respiratory syncytial virus infection (Primary phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 176 at risk

Adverse event: Bronchopneumonia (Primary phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 176 at risk

Adverse event: Gastroenteritis (Primary phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 176 at risk

Adverse event: Lower respiratory tract infection (Primary phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 176 at risk

Adverse event: Tracheitis (Primary phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 176 at risk

Adverse event: Urinary tract infection (Primary phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 176 at risk

Adverse event: Otitis media (Booster phase)
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 171 at risk

Adverse event: Cough (Primary phase)
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 9 affected / 176 at risk

Adverse event: Cough (Booster phase)
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 11 affected / 171 at risk

Adverse event: Pain (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 110 affected / 176 at risk

Adverse event: Redness (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 135 affected / 176 at risk

Adverse event: Swelling (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 105 affected / 176 at risk

Adverse event: Pain (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 93 affected / 169 at risk

Adverse event: Redness (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 115 affected / 169 at risk

Adverse event: Swelling (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 99 affected / 169 at risk

Adverse event: Drowsiness (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 130 affected / 176 at risk

Adverse event: Fever- rectal (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 116 affected / 176 at risk

Adverse event: Irritability (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 158 affected / 176 at risk

Adverse event: Loss of appetite (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 88 affected / 176 at risk

Adverse event: Drowsiness (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 79 affected / 169 at risk

Adverse event: Fever- rectal (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 78 affected / 169 at risk

Adverse event: Irritability (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 104 affected / 169 at risk

Adverse event: Loss of appetite (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 56 affected / 169 at risk

Adverse event: Pyrexia (Primary phase)
Serious: no
Organ System: General disorders
Frequency: 12 affected / 176 at risk

Adverse event: Pyrexia (Booster phase)
Serious: no
Organ System: General disorders
Frequency: 10 affected / 171 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 8 affected / 176 at risk

Adverse event: Vomiting
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 10 affected / 176 at risk

Adverse event: Nasopharyngitis (Primary phase)
Serious: no
Organ System: Infections and infestations
Frequency: 46 affected / 176 at risk

Adverse event: Nasopharyngitis (Booster phase)
Serious: no
Organ System: Infections and infestations
Frequency: 20 affected / 171 at risk

Adverse event: Otitis media (Booster phase)
Serious: no
Organ System: Infections and infestations
Frequency: 7 affected / 171 at risk